Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Medical center of the Main Administration for Service to the Diplomatic Corps, Moscow, Russian Federation
Soonchunhyang University Seoul Hospital, Seoul, Korea, Republic of
Ronald Reagan UCLA Medical Center, Department of Anesthesiology, Los Angeles, California, United States
Women and Chidren's Hospital Of Buffalo, Buffalo, New York, United States
National Taiwan University Hospital, Taipei, Taiwan
Mustafa Kemal University Medicine Faculty Anesthesiology Department, Hatay, Turkey
First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China
Theodor Bilharz Research Institute, Giza, Egypt
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.